Cytokinetics (CYTK) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Cytokinetics

    NASDAQ: CYTK · Real-Time Price · USD
    52.00
    0.50 (0.97%)
    At close: Sep 10, 2025, 3:59 PM
    52.00
    0.00%
    After-hours: Sep 10, 2025, 06:17 PM EDT

    Cytokinetics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 18.47M 7.53M 94.59M 70.43M
    Cost of Revenue
    		 339.41M 330.12M 240.81M 159.94M
    Gross Profit
    		 -320.93M -322.59M -146.22M -89.51M
    Operating Income
    		 -536.25M -496.2M -324.2M -186.31M
    Interest Income
    		 51.53M 27.63M 11.34M 331K
    Pretax Income
    		 -589.53M -526.24M -388.95M -215.31M
    Net Income
    		 -589.53M -526.24M -388.95M -215.31M
    Selling & General & Admin
    		 215.31M 173.61M 177.98M 96.8M
    Research & Development
    		 339.41M 330.12M 240.81M 159.94M
    Other Expenses
    		 -339.41M -330.12M -240.81M -159.94M
    Operating Expenses
    		 215.31M 173.61M 177.98M 96.8M
    Interest Expense
    		 86.51M 57.67M 51.16M 29.33M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 554.72M 503.74M 418.79M 256.74M
    Income Tax Expense
    		 n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 111.98M 96.52M 89.83M 76.89M
    Shares Outstanding (Diluted)
    		 111.98M 96.52M 89.83M 76.89M
    EPS (Basic)
    		 -5.26 -5.45 -4.33 -2.8
    EPS (Diluted)
    		 -5.26 -5.45 -4.33 -2.8
    EBITDA
    		 -493.48M -456.68M -329.4M -176.34M
    EBIT
    		 -503.01M -468.58M -337.8M -185.98M
    Depreciation & Amortization
    		 9.53M 11.89M 8.4M 9.64M

    Add to Watchlist